CD8A and neoplasm: Notably, CD8+ tumour-infiltrating lymphocytes (TILs) are crucial effectors of antitumour activity, producing interleukin (IL)2, IL-12 and interferon (IFN)-γ, which facilitate the destruction of tumour cells [15,16,17].